Ocular Biometrics in a French Population
Ocular Biometric Measurements in Cataract Surgery Candidates in The South of France : a Multicenter Cross Sectional Study
1 other identifier
observational
11,650
1 country
1
Brief Summary
The investigators aimed to study ocular biometrics parameters and their association with age, gender and the prevalence of high myopia in a population of cataract surgery candidates in the South of France. The investigators also aimed to define proportion of an "usual eye" and know the rate of inhomogeneous eyes in our population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2021
CompletedFirst Submitted
Initial submission to the registry
July 19, 2021
CompletedFirst Posted
Study publicly available on registry
August 5, 2021
CompletedAugust 5, 2021
July 1, 2021
6 months
July 19, 2021
July 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of patients with Distribution of ocular biometrics
Distribution of ocular biometrics and their association with age and gender
1 day
Secondary Outcomes (2)
number of patients with Prevalence of high myopia
1 day
rate of inhomogeneous eyes
1 day
Eligibility Criteria
patients who underwent ocular biometrics before cataract surgery
You may qualify if:
- aged 40 years
- olderpatients who underwent ocular biometrics before cataract surgery
You may not qualify if:
- previous cataract surgery
- age \< 40 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UH Montpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Vincent DAIEN, MD, PhD, HDR
University Hospitals of Montpellier
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2021
First Posted
August 5, 2021
Study Start
January 1, 2021
Primary Completion
July 1, 2021
Study Completion
July 10, 2021
Last Updated
August 5, 2021
Record last verified: 2021-07